April 11, 2021
Business News

Tenax Therapeutics, Inc. Expands Board of Directors

MORRISVILLE, N.C.–()–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced the appointment of four new members to its board of directors: June Almenoff, MD, PhD, Michael Davidson, MD, Delcan Doogan, MD, and Stuart Rich, MD.

“We are thrilled to welcome June, Michael, Declan and Stuart to our Board of Directors,” said Anthony DiTonno, Chief Executive Officer of Tenax Therapeutics. “Together, these highly accomplished professionals will provide the Board with significant scientific and commercial perspectives that will prove invaluable as we execute on…

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Fed Reserve chairman gives rosy economic forecast as Pelosi pushes back – New York Post
Article feature image
CEOs Plan New Push on Voting Legislation – The Wall Street Journal
Article feature image
Routes: New Calif. airline, Alaska lounge at SFO, more OAK routes, Hawaii rule changes, more – SF Gate